Mycophenolate mofetil Completed Phase 2 Trials for Blood and Marrow Transplant (BMT) / Non-Hodgkin's Lymphoma (NHL) / Leukemias Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00350181Sirolimus and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Myeloablative Matched Related Donor Hematopoietic Cell Transplant